Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Front Immunol ; 10: 542, 2019.
Article in English | MEDLINE | ID: mdl-30972056

ABSTRACT

B cells are salient features of pancreatic ductal adenocarcinoma (PDAC) tumors, yet their role in this disease remains controversial. Murine studies have indicated a protumoral role for B cells, whereas clinical data show tumor-infiltrating B cells are a positive prognostic factor, both in PDAC and other cancers. This disparity needs to be clarified in order to develop effective immunotherapies. In this study, we provide new evidence that reconcile human and mouse data and highlight the importance of using relevant preclinical tumor models when assessing B cell function. We compared B cell infiltration and activation in both a genetic model of murine PDAC (KPC mouse) and an injectable orthotopic model. A pronounced B cell infiltrate was only observed in KPC tumors and correlated with T cell infiltration, mirroring human disease. In contrast, orthotopic tumors exhibited a relative paucity of B cells. Accordingly, KPC-derived B cells displayed markers of B cell activation (germinal center entry, B cell memory, and plasma cell differentiation) accompanied by significant intratumoral immunoglobulin deposition, a feature markedly weaker in orthotopic tumors. Tumor immunoglobulins, however, did not appear to form immune complexes. Furthermore, in contrast to the current paradigm that tumor B cells are immunosuppressive, when assessed as a bulk population, intratumoral B cells upregulated several proinflammatory and immunostimulatory genes, a distinctly different phenotype to that of splenic-derived B cells; further highlighting the importance of studying tumor-infiltrating B cells over B cells from secondary lymphoid organs. In agreement with the current literature, genetic deletion of B cells (µMT mice) resulted in reduced orthotopic tumor growth, however, this was not recapitulated by treatment with B-cell-depleting anti-CD20 antibody and, more importantly, was not observed in anti-CD20-treated KPC mice. This suggests the result from B cell deficient mice might be caused by their altered immune system, rather than lack of B cells. Therefore, our data indicate B cells do not favor tumor progression. In conclusion, our analysis of relevant preclinical models shows B cells to be active members of the tumor microenvironment, producing immunostimulatory factors that might support the adaptive antitumor immune response, as suggested by human PDAC studies.


Subject(s)
B-Lymphocytes/immunology , Carcinoma, Pancreatic Ductal/immunology , Lymphocytes, Tumor-Infiltrating/immunology , Pancreatic Neoplasms/immunology , Tumor Microenvironment/immunology , Animals , Antigens, CD20/immunology , Disease Models, Animal , Female , Lymphocyte Activation/immunology , Male , Mice , Mice, Inbred C57BL , Pancreas/cytology , Pancreas/immunology , Pancreas/pathology , Pancreatic Neoplasms/pathology , T-Lymphocytes/immunology , Pancreatic Neoplasms
2.
J Immunol ; 175(5): 3207-13, 2005 Sep 01.
Article in English | MEDLINE | ID: mdl-16116211

ABSTRACT

IL-13 is a Th2-derived cytokine associated with pathological changes in asthma and ulcerative colitis. Moreover, it plays a major role in the control of gut nematode infection and associated immunopathology. The current paradigm is that these effects are due to T cell-derived IL-13. We show in this study that an innate source of IL-13, the intraepithelial NK cell, is responsible for the disruption of intestinal tissue architecture and induction of goblet cell hyperplasia that characterizes infection with the intestinal helminth Trichinella spiralis. IL-13 or IL-4Ralpha (but not IL-4) null mice failed to induce intestinal pathology. Unexpectedly, SCID and athymic mice developed the same pathology found in immunocompetent mice following infection. Moreover, immunodeficient mice expressed IL-13 in the intestine, and abnormal mucosal pathology was reduced by in vivo administration of a soluble IL-13 antagonist. IL-13 expression was induced in non-T intraepithelial CD3- NK cells. Epithelial cells expressed the IL-13 signaling receptor, IL-13Ralpha1, and after infection, IL-4Ralpha. Furthermore, the soluble IL-13 decoy receptor IL-13Ralpha2, which regulates IL-13 responses, was also induced upon infection. These data provide the first evidence that intestinal tissue restructuring during helminth infection is an innate event dependent on IL-13 production by NK cells resident in the epithelium of the intestine.


Subject(s)
Interleukin-13/physiology , Intestinal Mucosa/immunology , Intestines/pathology , Killer Cells, Natural/immunology , Trichinella spiralis , Trichinellosis/pathology , Animals , Interleukin-13 Receptor alpha1 Subunit , Interleukin-4/physiology , Leukocyte Common Antigens/analysis , Mice , Mice, Inbred BALB C , Mice, SCID , Plant Lectins/analysis , Receptors, Interleukin/physiology , Receptors, Interleukin-13 , Receptors, Interleukin-4/physiology , Trichinellosis/immunology
3.
Proc Natl Acad Sci U S A ; 100(13): 7761-6, 2003 Jun 24.
Article in English | MEDLINE | ID: mdl-12796512

ABSTRACT

We have investigated the influence of mast cells on the barrier function of intestinal epithelium during nematode infection. Trichinella spiralis infection induces a strong type 2 cytokine-mediated inflammation, resulting in a critical mucosal mastocytosis that is known to mediate expulsion of the parasites from the intestine. The host response to infection is also characterized by an increase in mucosal leakiness. We show here that intestinal epithelial permeability is markedly elevated during infection, with kinetics that mirror the adaptive immune response to primary and secondary infection. Furthermore, we have identified degradation of the tight junction protein, occludin, thereby providing a mechanism for increased paracellular permeability during helminth infection. We further demonstrate by using anti-c-kit antibody and IL-9 transgenic mice that mast cells are directly responsible for increasing epithelial paracellular permeability and that mice deficient in a mast cell-specific protease fail to increase intestinal permeability and fail to expel their parasite burden. These results provide the mechanism whereby mucosal mast cells mediate parasite expulsion from the intestine.


Subject(s)
Epithelium/parasitology , Intestines/parasitology , Mast Cells/metabolism , Trichinella spiralis/pathogenicity , Animals , Blotting, Western , Chemokine CCL2/genetics , Epithelial Cells/parasitology , Epithelium/metabolism , Epithelium/physiology , Immunoglobulin G/metabolism , Inflammation , Interleukin-9/genetics , Jejunum/parasitology , Membrane Proteins/metabolism , Mice , Mice, Inbred BALB C , Mice, Transgenic , Mucous Membrane/metabolism , Occludin , Proto-Oncogene Proteins c-kit/immunology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...